|
It would most probably be more profitable,
if the cure consisted of an ongoing treatment (vs a 1-time vaccine or cure).
I also think that if profiteering were involved,
selling it at a price more ppl could afford would get higher overall profits.
the sweet spot between volume & profit margin would depend on the cost of producing the said medication.
Say you offer it at $1,000, and even offer credit.
A lot of ppl (hundred of thousands, if not millions) would be lining up to buy this.
this risk is more conservative, as you're relying a wider customer pool.
Say in another scenario you sell it for 1 Million Dollars!!
You'll be lucky if you even see 1,000 rich dudes with AIDS to buy this.
Smaller, riskier customer base.
|